Rozanolixizumab improved symptoms in people with generalised myasthenia gravis in the MycarinG clinical study: a Plain Language Summary of Publication
Bibliographic record
Abstract
Plain Language SummaryWhat is this summary about?This is a summary of an article that describes the results of the MycarinG clinical study.Generalised myasthenia gravis is a rare, chronic (long-lasting) and fluctuating autoimmune disease that causes muscle weakness and fatigue (a sense of exhaustion). These symptoms can significantly impact the quality of life of people living with the disease, and their caregivers and families. Conventional treatments for myasthenia gravis do not always work well, and often have side effects that can limit their use, so there is a need for new and improved treatments. The MycarinG clinical study looked at whether taking rozanolixizumab once per week for 6 weeks was better at treating symptoms of generalised myasthenia gravis than a placebo.What were the results?The results of this 18-week study showed that symptoms of myasthenia gravis improved by a larger extent for people who took rozanolixizumab than for people who took placebo. The most common side effects with rozanolixizumab were headache, diarrhoea, fever and nausea.What do the results mean?These results mean that rozanolixizumab was an effective treatment for myasthenia gravis. The efficacy and safety of rozanolixizumab when taken for a longer period of time are being assessed in an extension of this study.How to say…Rozanolixizumab: Roh-ZAN-oh-lix-IZ-oo-mabMyasthenia gravis: My-as-THEEN-ee-a GRAH-vissPlacebo: Pluh-SEE-bohAcetylcholine: A-SIT-ile-KOH-leenQuality of life: Overall well-being including personal health, comfort and ability to participate in life events.Side effects: Unintended effects while taking a medication.Placebo: A medicine that looks and feels (and, if relevant, tastes) the same as the active treatment, but contains no active ingredients. A placebo may be used in clinical studies to ensure doctors are not biased when reporting their experience, by making sure they remain unaware of whether the patients are on treatment or not.Efficacy: The ability of a drug to produce a desired effect.Extension: An additional period after the observational period where patients can continue to take the medication if they want to. The extension period helps to understand the safety and efficacy of a treatment over a longer period of time than the initial clinical trial period.This is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article here
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.019 | 0.044 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.004 | 0.004 |
| Bibliometrics | 0.002 | 0.003 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.005 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.003 |
| Insufficient payload (model declined to judge) | 0.015 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".